Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lead | 6 | 2008 | 93 | 0.620 |
Why?
|
| Conditioning, Operant | 7 | 2008 | 73 | 0.510 |
Why?
|
| Animals, Newborn | 4 | 2005 | 343 | 0.470 |
Why?
|
| Cocaine | 4 | 2007 | 232 | 0.390 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2008 | 162 | 0.320 |
Why?
|
| Reinforcement Schedule | 3 | 2006 | 14 | 0.310 |
Why?
|
| Cocaine-Related Disorders | 2 | 2005 | 85 | 0.300 |
Why?
|
| Self Administration | 7 | 2008 | 42 | 0.260 |
Why?
|
| Bicuculline | 1 | 2005 | 18 | 0.260 |
Why?
|
| GABA Antagonists | 1 | 2005 | 29 | 0.260 |
Why?
|
| Extinction, Psychological | 1 | 2006 | 90 | 0.250 |
Why?
|
| Narcotics | 1 | 2003 | 32 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2003 | 57 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2008 | 1618 | 0.220 |
Why?
|
| Morphine | 1 | 2003 | 85 | 0.210 |
Why?
|
| Rats | 10 | 2008 | 3483 | 0.180 |
Why?
|
| Body Weight | 6 | 2010 | 434 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2008 | 1039 | 0.160 |
Why?
|
| Methamphetamine | 2 | 2008 | 159 | 0.130 |
Why?
|
| Lactation | 2 | 2004 | 40 | 0.120 |
Why?
|
| Pregnancy | 7 | 2008 | 1549 | 0.110 |
Why?
|
| Animals | 12 | 2011 | 15081 | 0.110 |
Why?
|
| Eating | 2 | 2005 | 166 | 0.110 |
Why?
|
| Phencyclidine | 1 | 2011 | 19 | 0.100 |
Why?
|
| Biogenic Monoamines | 1 | 2011 | 31 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 68 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2011 | 233 | 0.090 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2008 | 4 | 0.080 |
Why?
|
| Reward | 2 | 2007 | 79 | 0.080 |
Why?
|
| Lead Poisoning | 1 | 2008 | 26 | 0.080 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2007 | 8 | 0.080 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2008 | 65 | 0.070 |
Why?
|
| Male | 10 | 2011 | 20025 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2007 | 79 | 0.070 |
Why?
|
| Female | 10 | 2011 | 20969 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2005 | 22 | 0.070 |
Why?
|
| Cadmium Poisoning | 1 | 2004 | 2 | 0.060 |
Why?
|
| Heroin | 1 | 2004 | 13 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2004 | 29 | 0.060 |
Why?
|
| Behavior, Addictive | 1 | 2003 | 32 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 730 | 0.050 |
Why?
|
| Dibenzocycloheptenes | 1 | 2011 | 1 | 0.030 |
Why?
|
| Reversal Learning | 1 | 2011 | 4 | 0.030 |
Why?
|
| Globulins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 19 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2010 | 20 | 0.020 |
Why?
|
| Albumins | 1 | 2010 | 26 | 0.020 |
Why?
|
| Bilirubin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 50 | 0.020 |
Why?
|
| Caribbean Region | 1 | 2010 | 69 | 0.020 |
Why?
|
| Minerals | 1 | 2010 | 47 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 103 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 136 | 0.020 |
Why?
|
| Triglycerides | 1 | 2010 | 138 | 0.020 |
Why?
|
| Cholesterol | 1 | 2010 | 205 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2010 | 230 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 353 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 1369 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2007 | 141 | 0.020 |
Why?
|
| Serotonin | 1 | 2007 | 123 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 126 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2005 | 207 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 47 | 0.020 |
Why?
|
| Motivation | 1 | 2008 | 436 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 314 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2003 | 38 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 1371 | 0.010 |
Why?
|